Contineum Therapeutics CTNM
NASDAQ CTNM
$13.12 +0.13 (+1.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Contineum Therapeutics (CTNM) Net Preferred Shares Issued and Repurchased (2023)

Updated

Contineum Therapeutics (CTNM) recorded Net Preferred Shares Issued and Repurchased of $60.14 million in FY2023.

Analysis

Contineum Therapeutics (CTNM) Net Preferred Shares Issued and Repurchased (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Contineum Therapeutics 491.58 Mn 491.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 10.24 Mn
API Access

Contineum Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=CTNM&period=max&api_key=YOUR_API_KEY